ARA-290

What it is

ARA-290 (cibinetide) is an 11-amino-acid peptide derived from the helix B domain of erythropoietin (EPO). Unlike EPO itself it is non-erythropoietic, and it is studied in research models for its interaction with the innate repair receptor (IRR) rather than the classical erythropoietin receptor.

Supplied as a lyophilized powder and sealed against light and moisture — shelf-stable, no cold chain required. Every lot is assayed by an independent laboratory and the certificate is published before the compound is listed. Strictly for in-vitro laboratory research.

Research applications

• Lab-grade peptide for consistent and reliable research outcomes
• Used in innate repair receptor (IRR) signalling studies
• Non-erythropoietic EPO derivative — separates tissue-protective signalling from erythropoiesis in model systems
• High purity and stability for accurate experimental results

Storage & handling

For laboratory and research use only. Reconstitute using sterile techniques and follow all safety protocols. Store lyophilized peptide in a cool, dry place. Not for human consumption.

Research notes

• Can this peptide be used for human injections? No. Intended only for research and laboratory use.
• How should it be stored? Keep in a cool, dry place, protected from light. Refrigeration may be required after reconstitution.
• What is the shelf life? Stable for up to 24 months when stored properly in lyophilized form.
• Is it sterile? Yes, supplied as sterile lyophilized powder for laboratory applications.

Specifications

• Form: Lyophilized powder
• Purity: ≥99% (HPLC verified)
• Presentation: 10mg
• Storage: Store lyophilized at −20°C; protect from light.